Bayko Liisa Ann bought KLRS
July 20, 2026 · Form 4 insider transaction
Bayko Liisa Ann bought 220,000 shares of Kalaris Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
220,000
Price
$0.00
Total value
N/A
InsiderBayko Liisa Ann
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 20, 2026
Filing dateJuly 20, 2026
Shares owned after220,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option was granted on July 20, 2026. The shares underlying the option are scheduled to vest over four years, with 25% of the shares underlying the option vesting on July 20, 2027 and the remainder vesting in equal monthly installments thereafter, subject to continuous service.